Jules A. Maltz - Jul 30, 2021 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Signature
Soleil Boughton - Attorney-in-Fact
Stock symbol
HIMS
Transactions as of
Jul 30, 2021
Transactions value $
$1,310,046
Form type
4
Date filed
8/3/2021, 09:00 PM
Next filing
Dec 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Options Exercise $3.42K +297 +0.55% $11.50 54.2K Jul 30, 2021 Held by Institutional Venture Partners XV Executive Fund, L.P. F1, F3
transaction HIMS Class A Common Stock Options Exercise $652K +56.7K +0.56% $11.50 10.2M Jul 30, 2021 Held by Institutional Venture Partners XV, L.P. F1, F3
transaction HIMS Class A Common Stock Options Exercise $655K +57K +0.56% $11.50 10.2M Jul 30, 2021 Held by Institutional Venture Partners XVI, L.P. F1, F3
transaction HIMS Class A Common Stock Tax liability -218 -0.4% 54K Jul 30, 2021 Held by Institutional Venture Partners XV Executive Fund, L.P. F1, F2, F3
transaction HIMS Class A Common Stock Tax liability -41.5K -0.41% 10.1M Jul 30, 2021 Held by Institutional Venture Partners XV, L.P. F1, F2, F3
transaction HIMS Class A Common Stock Tax liability -41.8K -0.41% 10.2M Jul 30, 2021 Held by Institutional Venture Partners XVI, L.P. F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Warrant (right to buy) Options Exercise $0 -297 -50% $0.00 297 Jul 30, 2021 Class A Common Stock 297 $11.50 Held by Institutional Venture Partners XV Executive Fund, L.P. F3
transaction HIMS Warrant (right to buy) Options Exercise $0 -56.7K -50% $0.00 56.7K Jul 30, 2021 Class A Common Stock 56.7K $11.50 Held by Institutional Venture Partners XV, L.P. F3
transaction HIMS Warrant (right to buy) Options Exercise $0 -57K -50% $0.00 57K Jul 30, 2021 Class A Common Stock 57K $11.50 Held by Institutional Venture Partners XVI, L.P. F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 IVP XV Executive Fund, IVP XV and IVP XVI (as defined below) exercised warrants to purchase shares of the Issuer's Class A Common Stock. The warrants were exercised on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, IVP XV Executive Fund, IVP XV and IVP XVI received 0.267 shares per warrant exercised and the Issuer withheld 0.733 shares per warrant exercised. The exercise of the warrants, the withholding of shares of Class A Common Stock in the cashless exercises and the resulting issuance of the net shares of Class A Common Stock were exempt under Rule 16b-3 of the Securities Exchange Act of 1934, as amended.
F2 Represents shares of Class A Common Stock withheld in connection with the cashless exercises.
F3 Mr. Maltz is a managing director of Institutional Venture Management XV LLC, which is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV Executive Fund") and Institutional Venture Partners XV, L.P. ("IVP XV"), and Institutional Venture Management XVI LLC, which is the general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). Mr. Maltz may be deemed a beneficial owner of the securities held by IVP XV Executive Fund, IVP XV and IVP XVI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.